EP0446271A4 - Control of fns variations of response emg - Google Patents
Control of fns variations of response emgInfo
- Publication number
- EP0446271A4 EP0446271A4 EP19900900525 EP90900525A EP0446271A4 EP 0446271 A4 EP0446271 A4 EP 0446271A4 EP 19900900525 EP19900900525 EP 19900900525 EP 90900525 A EP90900525 A EP 90900525A EP 0446271 A4 EP0446271 A4 EP 0446271A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- emg
- response
- time
- fns
- pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/395—Details of stimulation, e.g. nerve stimulation to elicit EMG response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
Definitions
- This invention relates to functional neuromuscular stimulation (FNS) and more particularly to improved control of FNS.
- FNS Fluorescenceal Neuromuscular Stimulation
- the patients need the support of a walker or canes or elbow crutches, and are unable to manually adjust FNS levels or pulse widths to compensate for that fatigue, since the time when such adjustment is necessary is exactly when the patients cannot divert attention and hands to anything else.
- Work on electrical stimulation of paraplegics has been done by this inventor and by others.
- References include:
- the stimulated muscles produce an EMG (electromyographic) signal at the stimulated site, in response to that stimulation, even in paralyzed parts of the body.
- This response-EMG undergoes pattern changes with the progression of muscle fatigue.
- the present invention employs pattern recognition of the response-EMG where pattern parameters are identified whose variation with time is a function of the progression of muscle fatigue. This time variation is employed to automatically adjust FNS pulse width and/or pulse level to compensate for that fatigue in an automatic manner that does not require the patient's attention. Additional embodiments of the present invention provide for diagnostic uses of this pattern recognition, and for muscle contractions other than for standing or walking.
- the present invention is especially beneficial for upper motor neuron paraplegic patients, certain guadraplegics, stoke patients and cerebral palsy patients.
- an improved system and method of automated control of Functional Neuromuscular Stimulation is provided for responsive to pattern variations of the Response-EMG (electromyographic) signal produced by the muscle in response to the FNS.
- FNS Functional Neuromuscular Stimulation
- FIG. 1 illustrates a response-EMG controlled FNS system coupled to a patient
- FIGS. 2(a) and 2(b) illustrate two patterns of typical response-EMG signals at FNS-stimulated quadricep muscles
- FIGS. 3(a) and 3(b) illustrate response-EMG waveforms before and after fatigue.
- a paraplegic patient 10 has electrodes 21, 22, 23 and 24 and sensors 31, 32, 33 and 34, attached to his (or her) legs 12, such as by an electrode gel. Electrodes 21, 22, 23 and 24 are coupled by electrical leads 41, 42, 42 and 44, respectively, to an FNS stimulator 40. Sensors 31/ 32, 33 and 34 are also attached to the patients leg 12, such as by an electrode gel, and are coupled via electrical leads 61, 62, 63 and 64 respectively, to an EMG Pattern Recognition Subsystem 60. The sensors 31 to 34 provide Response-EMG signals for coupling to the EMG Pattern Recognition Subsystem 60.
- the EMG Pattern Recognition Subsystem 60 analyzes the Response EMG signals, as discussed hereinafter, and outputs a first control signal 66, coupled to a FNS Level/Pulse Width Controller 50, which responsive thereto outputs a second control signal 55, coupled to the FNS Stimulator Subsystem 40.
- the FNS Stimulator 40 automatically adjusts the level and/or pulse width of the FNS signal outputs 41, 42, 43 and 44 responsive to the second control signal 55 as output from the FNS Controller 50.
- FIG. 1 illustrates a functional neuromuscular stimulation system.
- the FNS electrodes 21-24 are coupled to the skin at the vicinity of a muscle to be stimulated.
- the FNS stimulation subsystem selectively outputs FNS stimulus signals 41 to 44 coupled via leads 41 to 44 to the FNS electrodes 21 to 24.
- the EMG electrodes 31 to 34 are coupled in the vicinity of the muscle to be stimulated, for sensing response-EMG signals responsive to the FNS stimulation subsystem.
- An EMG pattern recognition subsystem selectively analyzes multiple Response-EMG signals over time, and selectively provides FNS control signals 61 to 64 via electrical leads 61 to 64 responsive to recognized deviations beyond a predefined threshold level of change in patterns of the response-EMG signals, where the changes of the pattern over time are changes relative to the EMG pattern within a specified small time interval after initial application of the FNS stimuli, and after each successive readjustment of FNS stimuli.
- An FNS adjustment subsystem adjusts the FNS stimulus signals responsive to changes over time in the EMG pattern as recognized by said EMG pattern recognition means, so as to prevent fatigue.
- the FNS and EMG electrodes are preferably attached to the surface of the skin, such as by use of an electrode gel. However, the FNS and EMG electrodes can alternatively be implanted beneath the surface of the skin. Pattern recognition can be accomplished in terms of measuring the point-wise difference over a given fixed number of points in the response-EMG voltage vs. time signals as obtained at the response- EMG electrodes between their voltage values at discrete time points immediately after any adjustment of stimulus level vs. the corresponding value at any time later when fatigue may have started to take effect.
- the time scales are all with respect to the time instant t Q of the initiation of each stimulus in a train of FNS stimuli, where each point considered in the two patterns that are compared is the same distance from the time instant of initiation point for each pattern.
- the area differences rather than point-wise differences are considered as the selected parameter to be analyzed as between EMG patterns.
- FNS electrodes are attached to the patient's legs, and coupled to a FNS stimulator subsystem, which periodically outputs electrical stimuli.
- EMG electrodes are attached to the patient's legs, coupled to an EMG pattern recognition subsystem which analyzes the response-EMG signals and responsive thereto selectively outputs a FNS adapted control signal.
- the FNS stimulator subsystem outputs stimulus signals to the FNS electrodes which are modified responsive to the control signal, so as to prevent fatigue in the patient.
- EMG signals are sensed from stimulated muscles as a response-EMG signal.
- the dynamic pattern of the response-EMG signals are repeatedly monitored over time and analyzed.
- a finite set of parameters associated with the pattern and capable of indicating a propensity of fatigue are analyzed.
- the control signal is provided to the FNS stimulator subsystem so as to modify the FNS stimuli coupled to the FNS electrodes so as to prevent fatigue.
- the finite set of parameters can be determined in accordance with a least squares polynomial fit to the response-EMG signal such as defined in Chapter 5 of Reference [6] set forth in the Background of the Invention herein.
- the finite set of parameters can be determined in terms of a transfer function fit to the response-EMG, where the response-EMG is considered as an impulse response, such that the transfer function becomes the inverse Laplace transform calculated for that impulse response which is the response-EMG pattern of EMG voltage vs. time, starting at the time instant at which the stimulus impulse is being applied by the stimulator.
- the finite set of parameters can be determined by analysis of deviation of the response-EMG pattern from its mean over time.
- the finite set of parameters can be determined by means of analysis of said response-EMG signals by analysis of differences between successive extremes of said pattern over time.
- an improved system and method overcomes loss of balance with the progress of muscle fatigue, by using response-EMG control of FNS in paraplegics who are standing or walking with a cane or walker or elbow- crutch support.
- the importance of such control in paraplegics is obvious, since paraplegics have no sensation of muscle fatigue.
- muscle fatigue has already caused loss of balance, in terms of knee bending, it is too late for the patient to adjust FNS levels or pulse width to strengthen stimulation.
- the patient cannot take his hands off his walker or crutches to adjust the FNS level or pulse width, nor can he even afford to divert his attention to perform such an adjustment.
- EMG control of FNS has been proposed using EMG signals from the stimulated muscles (i.e. "response-EMG") where the first or second peak of the EMG signal is employed.
- response-EMG EMG signals from the stimulated muscles
- peaks are widely varying in value and the EMG's shape may differ from patient to patient.
- the dynamic pattern of the response-EMG does change.
- pattern identification of this EMG is performed in terms of a finite set of parameters, p j ⁇ .-.p , and progression of fatigue is determined by repeatedly monitoring these parameters over time, such that when at least one significant parameter changes beyond a predetermined minimal percentage value, fatigue is considered to exist to a degree that requires automatic increase in FNS level and/or pulse width.
- pattern recognition can be in terms of parameters of a least squared polynomial fit to the EMG pattern or in terms of a transfer function fit. Since recognition is of differences between patterns (i.e., between patterns before and during muscle fatigue), recognition of differences can be directly implemented by measuring the point-wise difference either between the before and during curves of the response-EMG as in either of FIGS. 2(a) or 2(b) as obtained before and during muscle fatigue for successive points starting at the time of applying each stimulus to provide a time reference for comparison. In one embodiment, this can also be with respect to deviation of the pattern from its mean.
- the present invention utilizes change in pattern recognition parameters, not maximal values or peaks.
- changes in specified pattern recognition parameters or in area are the factor that determined fatigue.
- area or pattern recognition parameters need peak (reach maximum) in the non-fatigued response EMG in the present invention.
- area when area is considered they always happen (but need not) to be maximal at the non-fatigued situation.
- Other pattern recognition parameters are not always maximal in the non-fatigued situation, but can be utilized in accordance with the present invention.
- the controller considers the pattern before fatigue to be that response-EMG pattern (solid line in FIGS. 2(a)-2(b) obtained immediately following the first switching on of the stimulation or immediately following any increase in stimulation levels whereas the EMG pattern (dashed lines in FIGS. 2(a)-2(b)) during the progression of fatigue is considered to be any response-EMG pattern at the same electrode location at any time later. All patterns are compared as patterns of EMG voltage vs. time, where time is measured starting from the time tg at which any stimulation pulse is initiated or re-initiated by the stimulator, noting that these stimuli are applied and re-initiated at successive time intervals varying from between 20 and 50 milliseconds.
- FIGS. 2(a) and 2(b) two typical Response-EMG signal waveforms, as sensed by sensors 31-34, at FNS stimulated quadricep muscles, are illustrated. Numerous other waveform patterns may also occur.
- the first peak in each waveform represents the FNS Stimulation Artifact.
- the solid line waveforms represent the response-EMG pattern under no fatigue conditions.
- the dashed line waveforms represent progression of muscle fatigue conditions, measured at later times, which are sensed and utilized in accordance with the present invention, as described hereinabove.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Radiology & Medical Imaging (AREA)
- Medical Informatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Electrotherapy Devices (AREA)
- Electrical Control Of Ignition Timing (AREA)
- Output Control And Ontrol Of Special Type Engine (AREA)
- Control Of High-Frequency Heating Circuits (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/277,323 US5016635A (en) | 1988-11-29 | 1988-11-29 | Control of FNS via pattern variations of response EMG |
US277323 | 1988-11-29 | ||
PCT/US1989/005385 WO1990006152A1 (en) | 1988-11-29 | 1989-11-28 | Control of fns variations of response emg |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0446271A1 EP0446271A1 (en) | 1991-09-18 |
EP0446271A4 true EP0446271A4 (en) | 1993-01-07 |
EP0446271B1 EP0446271B1 (en) | 1996-04-10 |
Family
ID=23060357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP90900525A Expired - Lifetime EP0446271B1 (en) | 1988-11-29 | 1989-11-28 | Control of fns variations of response emg |
Country Status (6)
Country | Link |
---|---|
US (1) | US5016635A (en) |
EP (1) | EP0446271B1 (en) |
AU (1) | AU639898B2 (en) |
CA (1) | CA2004110A1 (en) |
DE (1) | DE68926243T2 (en) |
WO (1) | WO1990006152A1 (en) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5014705A (en) * | 1989-04-07 | 1991-05-14 | Sigmedics, Inc. Of Delaware | Microprocessor-controlled multiplexed functional electrical stimulator for surface stimulation in paralyzed patients |
US5300096A (en) * | 1992-06-03 | 1994-04-05 | Hall H Eugene | Electromyographic treatment device |
EP0700658B1 (en) * | 1994-09-10 | 1999-11-03 | Hewlett-Packard GmbH | A device and a method for equalizing a patient's potential with respect to medical equipment |
AU5870496A (en) * | 1995-07-31 | 1997-02-26 | Motorola, Inc. | Hybrid fes and active orthosis method and system for controlling the movement of a limb |
US5748845A (en) * | 1995-07-31 | 1998-05-05 | Motorola, Inc. | FES method and system for controlling the movement of a limb |
JP2000507111A (en) * | 1995-08-04 | 2000-06-13 | オリヴェ,ホセ ハビエル ロディエラ | Method and apparatus for monitoring and / or regulating neuromuscular blockade, particularly blockade caused by muscle relaxants used during anesthesia |
US5674262A (en) * | 1996-01-26 | 1997-10-07 | Kinetic Concepts, Inc. | Pneumatic compression and functional electric stimulation device and method using the same |
US8762065B2 (en) | 1998-08-05 | 2014-06-24 | Cyberonics, Inc. | Closed-loop feedback-driven neuromodulation |
US7242984B2 (en) | 1998-08-05 | 2007-07-10 | Neurovista Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US7231254B2 (en) | 1998-08-05 | 2007-06-12 | Bioneuronics Corporation | Closed-loop feedback-driven neuromodulation |
US9375573B2 (en) | 1998-08-05 | 2016-06-28 | Cyberonics, Inc. | Systems and methods for monitoring a patient's neurological disease state |
US7209787B2 (en) | 1998-08-05 | 2007-04-24 | Bioneuronics Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US7853329B2 (en) | 1998-08-05 | 2010-12-14 | Neurovista Corporation | Monitoring efficacy of neural modulation therapy |
US7324851B1 (en) | 1998-08-05 | 2008-01-29 | Neurovista Corporation | Closed-loop feedback-driven neuromodulation |
US7403820B2 (en) * | 1998-08-05 | 2008-07-22 | Neurovista Corporation | Closed-loop feedback-driven neuromodulation |
US9042988B2 (en) | 1998-08-05 | 2015-05-26 | Cyberonics, Inc. | Closed-loop vagus nerve stimulation |
US7277758B2 (en) | 1998-08-05 | 2007-10-02 | Neurovista Corporation | Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder |
US9415222B2 (en) | 1998-08-05 | 2016-08-16 | Cyberonics, Inc. | Monitoring an epilepsy disease state with a supervisory module |
US6366813B1 (en) | 1998-08-05 | 2002-04-02 | Dilorenzo Daniel J. | Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease |
US7747325B2 (en) | 1998-08-05 | 2010-06-29 | Neurovista Corporation | Systems and methods for monitoring a patient's neurological disease state |
BR9913610A (en) * | 1998-09-04 | 2001-10-09 | Wolfe Res Pty Ltd | Medical implant system |
US6411843B1 (en) | 1999-05-28 | 2002-06-25 | Respironics, Inc. | Method and apparatus for producing a model EMG signal from a measured EMG signal |
GB9922153D0 (en) * | 1999-09-21 | 1999-11-17 | Hutton Harry T | A telemetry system for monitoring nerve patterns and dynamically inducing physiological responses based on the intelligent adaptive mapping of nerve pattern r |
CA2419174A1 (en) * | 2000-08-14 | 2002-02-21 | Neopraxis Pty Ltd | Muscle fatigue meter |
US7497806B2 (en) * | 2000-08-14 | 2009-03-03 | Neopraxis Pty Ltd. | Exercise apparatus for a person with muscular deficiency |
US6644976B2 (en) | 2001-09-10 | 2003-11-11 | Epoch Innovations Ltd | Apparatus, method and computer program product to produce or direct movements in synergic timed correlation with physiological activity |
US6829510B2 (en) * | 2001-12-18 | 2004-12-07 | Ness Neuromuscular Electrical Stimulation Systems Ltd. | Surface neuroprosthetic device having an internal cushion interface system |
AU2002323810A1 (en) * | 2002-08-05 | 2004-02-23 | Japan As Represented By President Of National Cardiovascular Center | Medical treatment system using biological regulation function alternate, cardiac pacing system based on the medical treatment system, blood pressure regulating system, and cardiac disease treating system |
US8725243B2 (en) | 2005-12-28 | 2014-05-13 | Cyberonics, Inc. | Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
US8868172B2 (en) | 2005-12-28 | 2014-10-21 | Cyberonics, Inc. | Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders |
US20070213796A1 (en) * | 2006-03-10 | 2007-09-13 | Mcginnis William J | Ring electrode |
CA2956427C (en) | 2006-05-01 | 2021-08-17 | Bioness Neuromodulation Ltd. | Improved functional electrical stimulation systems |
EP2034885A4 (en) | 2006-06-23 | 2010-12-01 | Neurovista Corp | Minimally invasive monitoring systems and methods |
US8295934B2 (en) | 2006-11-14 | 2012-10-23 | Neurovista Corporation | Systems and methods of reducing artifact in neurological stimulation systems |
US9898656B2 (en) | 2007-01-25 | 2018-02-20 | Cyberonics, Inc. | Systems and methods for identifying a contra-ictal condition in a subject |
EP2124734A2 (en) * | 2007-01-25 | 2009-12-02 | NeuroVista Corporation | Methods and systems for measuring a subject's susceptibility to a seizure |
US8036736B2 (en) | 2007-03-21 | 2011-10-11 | Neuro Vista Corporation | Implantable systems and methods for identifying a contra-ictal condition in a subject |
WO2008137703A1 (en) * | 2007-05-04 | 2008-11-13 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Systems and methods for wireless transmission of biopotentials |
US9788744B2 (en) | 2007-07-27 | 2017-10-17 | Cyberonics, Inc. | Systems for monitoring brain activity and patient advisory device |
US8444571B2 (en) | 2007-09-25 | 2013-05-21 | Uroval, Inc. | Obtaining measurements of muscle reflexes for diagnosis of patient symptoms |
JP5591114B2 (en) | 2007-09-25 | 2014-09-17 | ウローバル インコーポレイテッド | A device to measure the bulbar cavernous reflex of a patient |
US9730605B2 (en) | 2007-09-25 | 2017-08-15 | Uroval, Inc. | Diagnosis of brain and spinal cord injury by bulbocavernosus reflex measurement |
US9259591B2 (en) | 2007-12-28 | 2016-02-16 | Cyberonics, Inc. | Housing for an implantable medical device |
US20090171168A1 (en) | 2007-12-28 | 2009-07-02 | Leyde Kent W | Systems and Method for Recording Clinical Manifestations of a Seizure |
US8892210B2 (en) | 2008-07-02 | 2014-11-18 | Niveus Medical, Inc. | Devices, systems, and methods for automated optimization of energy delivery |
US8285381B2 (en) * | 2008-07-02 | 2012-10-09 | Niveus Medical, Inc. | Systems and methods for automated muscle stimulation |
US8265763B2 (en) * | 2008-08-26 | 2012-09-11 | Niveus Medical, Inc. | Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema |
US9149386B2 (en) | 2008-08-19 | 2015-10-06 | Niveus Medical, Inc. | Devices and systems for stimulation of tissues |
US8849390B2 (en) | 2008-12-29 | 2014-09-30 | Cyberonics, Inc. | Processing for multi-channel signals |
US8588933B2 (en) | 2009-01-09 | 2013-11-19 | Cyberonics, Inc. | Medical lead termination sleeve for implantable medical devices |
WO2010093720A1 (en) | 2009-02-10 | 2010-08-19 | Nevro Corporation | Systems and methods for delivering neural therapy correlated with patient status |
WO2010096776A2 (en) | 2009-02-20 | 2010-08-26 | Niveus Medical, Inc. | Systems and methods of powered muscle stimulation using an energy guidance field |
US8786624B2 (en) | 2009-06-02 | 2014-07-22 | Cyberonics, Inc. | Processing for multi-channel signals |
US8498710B2 (en) * | 2009-07-28 | 2013-07-30 | Nevro Corporation | Linked area parameter adjustment for spinal cord stimulation and associated systems and methods |
AU2010319602B2 (en) | 2009-11-11 | 2015-09-24 | Sage Products, Llc | Synergistic muscle activation device |
US9643019B2 (en) | 2010-02-12 | 2017-05-09 | Cyberonics, Inc. | Neurological monitoring and alerts |
US20120245482A1 (en) * | 2010-09-16 | 2012-09-27 | Bolser Jeffrey W | Anesthesia Monitoring Device and Method |
US9380978B2 (en) * | 2011-06-29 | 2016-07-05 | Bruce Reiner | Method and apparatus for real-time measurement and analysis of occupational stress and fatigue and performance outcome predictions |
US20140074187A1 (en) * | 2012-04-23 | 2014-03-13 | Medtronic, Inc. | Electrode selection based on current source density analysis |
US9895538B1 (en) | 2013-01-22 | 2018-02-20 | Nevro Corp. | Systems and methods for deploying patient therapy devices |
US9295840B1 (en) | 2013-01-22 | 2016-03-29 | Nevro Corporation | Systems and methods for automatically programming patient therapy devices |
US9731133B1 (en) | 2013-01-22 | 2017-08-15 | Nevro Corp. | Systems and methods for systematically testing a plurality of therapy programs in patient therapy devices |
CA2866028A1 (en) | 2013-10-03 | 2015-04-03 | Farsad Kiani | Electrical stimulation for a functional electrical stimulation system |
CA2866027A1 (en) | 2013-10-03 | 2015-04-03 | Farsad Kiani | Controller unit for a functional electrical stimulation (fes) orthotic system |
CA2866025A1 (en) | 2013-10-03 | 2015-04-03 | Quiang Song | Sensor unit for a functional electrical stimulation (fes) orthotic system |
US9867985B2 (en) | 2014-03-24 | 2018-01-16 | Bioness Inc. | Systems and apparatus for gait modulation and methods of use |
CN106659891B (en) * | 2014-07-23 | 2019-11-22 | 电子系统股份有限公司 | Electrical stimulation device and training device |
US9364657B2 (en) | 2014-10-31 | 2016-06-14 | Ensilver Canada | Cuff unit for a functional electrical stimulation system |
US10300277B1 (en) | 2015-12-14 | 2019-05-28 | Nevro Corp. | Variable amplitude signals for neurological therapy, and associated systems and methods |
JP6771154B2 (en) * | 2016-01-07 | 2020-10-21 | パナソニックIpマネジメント株式会社 | Fall risk judgment device, how to operate the fall risk judgment device, and computer program |
JP7036728B2 (en) | 2016-01-11 | 2022-03-15 | バイオネス インコーポレイテッド | Systems and devices for gait adjustment and how to use them |
US10722745B2 (en) | 2018-06-05 | 2020-07-28 | The Chinese University Of Hong Kong | Interactive cycling system and method of using muscle signals to control cycling pattern stimulation intensity |
CN112773380B (en) * | 2019-11-07 | 2023-09-22 | 深圳市理邦精密仪器股份有限公司 | Myoelectric signal processing method, processing equipment and storage medium |
US11864898B2 (en) | 2020-11-06 | 2024-01-09 | Myocene | Muscle fatigue determination method and system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4838272A (en) * | 1987-08-19 | 1989-06-13 | The Regents Of The University Of California | Method and apparatus for adaptive closed loop electrical stimulation of muscles |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4213467A (en) * | 1978-08-11 | 1980-07-22 | Harvard College, President And Fellows | Monitoring myoelectric signals |
US4291705A (en) * | 1979-09-10 | 1981-09-29 | The Regents Of The University Of California | Neuromuscular block monitor |
US4361559A (en) * | 1981-08-20 | 1982-11-30 | E. R. Squibb & Sons, Inc. | Antiinflammatory 17,17-bis (substituted thio) androstenes |
US4622973A (en) * | 1984-06-15 | 1986-11-18 | Empi, Inc. | Programmable functional electrical stimulation system |
US4669477A (en) * | 1985-05-20 | 1987-06-02 | Empi, Inc. | Apparatus and method for preventing bruxism |
US4805636A (en) * | 1986-02-24 | 1989-02-21 | The University Of Michigan | System for controlling muscle response |
US4753246A (en) * | 1986-03-28 | 1988-06-28 | The Regents Of The University Of California | EEG spatial filter and method |
US4750499A (en) * | 1986-08-20 | 1988-06-14 | Hoffer Joaquin A | Closed-loop, implanted-sensor, functional electrical stimulation system for partial restoration of motor functions |
-
1988
- 1988-11-29 US US07/277,323 patent/US5016635A/en not_active Expired - Fee Related
-
1989
- 1989-11-28 DE DE68926243T patent/DE68926243T2/en not_active Expired - Fee Related
- 1989-11-28 EP EP90900525A patent/EP0446271B1/en not_active Expired - Lifetime
- 1989-11-28 WO PCT/US1989/005385 patent/WO1990006152A1/en active IP Right Grant
- 1989-11-28 AU AU47504/90A patent/AU639898B2/en not_active Ceased
- 1989-11-29 CA CA002004110A patent/CA2004110A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4838272A (en) * | 1987-08-19 | 1989-06-13 | The Regents Of The University Of California | Method and apparatus for adaptive closed loop electrical stimulation of muscles |
Non-Patent Citations (2)
Title |
---|
CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING vol. 15, no. 3, 1 March 1987, FLORIDA pages 187 - 210 GRAUPE,KOHN 'a critical review of emg-controlled electrical stimulation in paraplegics' * |
See also references of WO9006152A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE68926243D1 (en) | 1996-05-15 |
CA2004110A1 (en) | 1990-05-29 |
US5016635A (en) | 1991-05-21 |
WO1990006152A1 (en) | 1990-06-14 |
EP0446271A1 (en) | 1991-09-18 |
AU639898B2 (en) | 1993-08-12 |
DE68926243T2 (en) | 1996-11-07 |
AU4750490A (en) | 1990-06-26 |
EP0446271B1 (en) | 1996-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU639898B2 (en) | Control of fns variations of response emg | |
US11167129B2 (en) | Neural stimulation dosing | |
US11389110B2 (en) | Automated adaptive muscle stimulation method and apparatus | |
US4690142A (en) | Method and system for utilizing electro-neuro stimulation in a bio-feedback system | |
AU2002309179B2 (en) | Pacemaker for bilateral vocal cord autoparalysis | |
US8280516B2 (en) | Method and apparatus for closed-loop deep brain stimulation in treating neurological diseases | |
WO2011109199A2 (en) | Closed loop neural activity triggered rehabilitation device and method | |
US20210387002A1 (en) | Control policy settings for electrical stimulation therapy | |
CN115624694B (en) | Stimulation current control method, device, equipment, intelligent wearing device and medium | |
CN114901346A (en) | Gesture-based control of electrical stimulation therapy | |
Weber et al. | Sensory information feedback for neural prostheses | |
JP2000000232A (en) | Muscular fatigue judgement device | |
De Castro et al. | Artificial sensorimotor integration in spinal cord injured subjects through neuromuscular and electrotactile stimulation | |
US11247047B2 (en) | Electro-stimulation system for muscle location identification and therapeutic response enhancement | |
de Sousa et al. | Automatic detection of stimulation artifacts to isolate volitional from evoked emg activity | |
JPH04503462A (en) | Control of FNS fluctuation of response EMG | |
Popovic | Neural prostheses for movement restoration | |
US20210386991A1 (en) | Maintaining temporal resolution of evoked compound action potential (ecap) therapy data in memory constrained system | |
Zhang et al. | Modulation Ranges of Different Sensations for Coding Electrically Evoked Tactile Sensory Feedback | |
WO2024025813A1 (en) | Determining location of medical lead during implantation | |
Carhart et al. | Epidural spinal cord stimulation and partial weight-bearing therapy for the restoration of locomotion | |
Sabut et al. | A portable neuroprosthesis for applications in gait rehabilitations with stroke patients | |
Baker | The effects of sub-threshold electrical stimulation on neuromuscular activation | |
JP2005517485A (en) | Biomedical device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19910523 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): CH DE FR GB IT LI NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19921116 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): CH DE FR GB IT LI NL SE |
|
17Q | First examination report despatched |
Effective date: 19940812 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): CH DE FR GB IT LI NL SE |
|
REF | Corresponds to: |
Ref document number: 68926243 Country of ref document: DE Date of ref document: 19960515 |
|
ITF | It: translation for a ep patent filed |
Owner name: MODIANO & ASSOCIATI S.R.L. |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: PATENTANWAELTE SCHAAD, BALASS, MENZL & PARTNER AG |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19971112 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19971117 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19971119 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19971130 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19971205 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19971209 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981129 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990601 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19981128 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990730 |
|
EUG | Se: european patent has lapsed |
Ref document number: 90900525.8 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 19990601 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19991001 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20051128 |